Clinical Trial Update: [F-18]Fluoro-DOPA PET Imaging of Brain Tumors in Children

View source ↗

Summary

The clinical trial evaluating [18F]Fluoro-DOPA PET imaging for brain tumors in children has been withdrawn from the registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors

Drugs mentioned

• [18F]Fluoro-DOPA (fluorodopa)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Brain Tumors | Status: WITHDRAWN